• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从婴儿期到成年期的低磷血症性佝偻病的治疗管理。

Therapeutic management of hypophosphatemic rickets from infancy to adulthood.

机构信息

Service d'Endocrinologie et Diabétologie de l'Enfant Service de Pédiatrie générale - Consultation de rhumatologie Service d'Endocrinologie et des Maladies de la Reproduction Service d'ORL et chirurgie cervico-maxillo-facialeHôpital Bicêtre, APHP, 78 rue du Général Leclerc, 94270 Le Kremlin Bicêtre, France Université Paris 11Faculté de Médecine, Hôpital Bicêtre, 70 rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France Centre de Référence des Maladies Rares du Métabolisme du Calcium et du PhosphoreLe Kremlin-Bicêtre, France Service d'Odontologie-Maladies Rares Hôpital Bretonneau 2 rue Carpeaux75018 Paris, France Université Paris Descartes 12 Rue de l'École de Médecine75006 Paris, France Service Rhumatologie B Hôpital CochinAPHP, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France Centre de Référence des Maladies Rares des Maladies Auto-Inflammatoires Rares de l'EnfantLe Kremlin Bicêtre, France Service d'explorations fonctionnelles rénales Service de Chirurgie infantile orthopédiqueHôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France Association de patients RVRH-XLH20 rue Merlin de Thionville, 92150 Suresnes, France.

出版信息

Endocr Connect. 2014 Mar 14;3(1):R13-30. doi: 10.1530/EC-13-0103. Print 2014.

DOI:10.1530/EC-13-0103
PMID:24550322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3959730/
Abstract

In children, hypophosphatemic rickets (HR) is revealed by delayed walking, waddling gait, leg bowing, enlarged cartilages, bone pain, craniostenosis, spontaneous dental abscesses, and growth failure. If undiagnosed during childhood, patients with hypophosphatemia present with bone and/or joint pain, fractures, mineralization defects such as osteomalacia, entesopathy, severe dental anomalies, hearing loss, and fatigue. Healing rickets is the initial endpoint of treatment in children. Therapy aims at counteracting consequences of FGF23 excess, i.e. oral phosphorus supplementation with multiple daily intakes to compensate for renal phosphate wasting and active vitamin D analogs (alfacalcidol or calcitriol) to counter the 1,25-diOH-vitamin D deficiency. Corrective surgeries for residual leg bowing at the end of growth are occasionally performed. In absence of consensus regarding indications of the treatment in adults, it is generally accepted that medical treatment should be reinitiated (or maintained) in symptomatic patients to reduce pain, which may be due to bone microfractures and/or osteomalacia. In addition to the conventional treatment, optimal care of symptomatic patients requires pharmacological and non-pharmacological management of pain and joint stiffness, through appropriated rehabilitation. Much attention should be given to the dental and periodontal manifestations of HR. Besides vitamin D analogs and phosphate supplements that improve tooth mineralization, rigorous oral hygiene, active endodontic treatment of root abscesses and preventive protection of teeth surfaces are recommended. Current outcomes of this therapy are still not optimal, and therapies targeting the pathophysiology of the disease, i.e. FGF23 excess, are desirable. In this review, medical, dental, surgical, and contributions of various expertises to the treatment of HR are described, with an effort to highlight the importance of coordinated care.

摘要

在儿童中,低磷血症性佝偻病(HR)表现为行走延迟、鸭步、下肢弯曲、软骨增大、骨痛、颅缝早闭、自发性牙脓肿和生长发育迟缓。如果在儿童期未被诊断出,低磷血症患者会出现骨骼和/或关节疼痛、骨折、骨软化症等矿化缺陷、肌腱病、严重的牙齿异常、听力损失和疲劳。佝偻病的愈合是儿童治疗的初始终点。治疗旨在对抗 FGF23 过多的后果,即通过多次每日摄入口服补充磷以补偿肾脏磷的丢失,并使用活性维生素 D 类似物(阿尔法骨化醇或骨化三醇)来对抗 1,25-二羟维生素 D 缺乏症。在生长结束时偶尔会对残余下肢弯曲进行矫正手术。由于成人治疗适应症缺乏共识,一般认为应重新开始(或维持)对有症状的患者进行药物治疗,以减轻疼痛,疼痛可能是由于骨微骨折和/或骨软化症引起的。除了常规治疗外,对有症状的患者进行最佳护理还需要通过适当的康复来进行药物和非药物治疗疼痛和关节僵硬。应特别注意 HR 的牙齿和牙周表现。除了改善牙齿矿化的维生素 D 类似物和磷酸盐补充剂外,还建议进行严格的口腔卫生、根尖脓肿的主动根管治疗以及牙齿表面的预防性保护。目前这种治疗的效果仍不理想,针对疾病病理生理学的治疗方法,即 FGF23 过多,是理想的治疗方法。在这篇综述中,描述了 HR 的医学、牙科、手术以及各种专业知识对治疗的贡献,努力强调协调护理的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/28b8a492b401/ec-03-R13-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/630d658ca4d2/ec-03-R13-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/846e1c1d583a/ec-03-R13-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/055ec6e8704f/ec-03-R13-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/da087463fece/ec-03-R13-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/28b8a492b401/ec-03-R13-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/630d658ca4d2/ec-03-R13-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/846e1c1d583a/ec-03-R13-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/055ec6e8704f/ec-03-R13-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/da087463fece/ec-03-R13-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/3959730/28b8a492b401/ec-03-R13-g005.jpg

相似文献

1
Therapeutic management of hypophosphatemic rickets from infancy to adulthood.从婴儿期到成年期的低磷血症性佝偻病的治疗管理。
Endocr Connect. 2014 Mar 14;3(1):R13-30. doi: 10.1530/EC-13-0103. Print 2014.
2
Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.X连锁低磷性佝偻病/骨软化症中骨病的治疗。磷和骨化三醇的诱导与维持治疗。
J Clin Invest. 1985 Jun;75(6):1858-68. doi: 10.1172/JCI111900.
3
Mineralized tissues in hypophosphatemic rickets.低血磷性佝偻病的矿化组织。
Pediatr Nephrol. 2020 Oct;35(10):1843-1854. doi: 10.1007/s00467-019-04290-y. Epub 2019 Aug 8.
4
Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.评估1,25-二羟维生素D3在X连锁低磷性佝偻病和骨软化症的发病机制及治疗中的作用。
J Clin Invest. 1980 Nov;66(5):1020-32. doi: 10.1172/JCI109930.
5
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.X 连锁低磷血症和 FGF23 相关低磷血症疾病:新治疗方法的前景。
Endocr Rev. 2018 Jun 1;39(3):274-291. doi: 10.1210/er.2017-00220.
6
X-linked hypophosphatemia: Management and treatment prospects.X 连锁低磷血症:管理与治疗前景。
Joint Bone Spine. 2019 Nov;86(6):731-738. doi: 10.1016/j.jbspin.2019.01.012. Epub 2019 Jan 31.
7
Management of X-linked hypophosphatemia in adults.成人 X 连锁低磷血症的管理。
Metabolism. 2020 Feb;103S:154049. doi: 10.1016/j.metabol.2019.154049. Epub 2019 Dec 18.
8
Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.低磷血症性佝偻病:FGF23对磷稳态调控紊乱的启示
Curr Osteoporos Rep. 2015 Apr;13(2):88-97. doi: 10.1007/s11914-015-0259-y.
9
[Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.].[佝偻病/骨软化症。FGF23相关低磷性佝偻病和骨软化症患者的抗FGF23抗体治疗。]
Clin Calcium. 2018;28(10):1373-1379.
10
A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets.PHEX基因突变是成人期维生素D抵抗性低磷性骨软化症的病因:该疾病并非与X连锁低磷性佝偻病不同的独立疾病的证据。
J Clin Endocrinol Metab. 1998 Oct;83(10):3459-62. doi: 10.1210/jcem.83.10.5167.

引用本文的文献

1
Management of rickets: the new horizons for the pediatrician.佝偻病的管理:儿科医生的新视野
J Health Popul Nutr. 2025 Aug 26;44(1):310. doi: 10.1186/s41043-025-00885-4.
2
Oral Health Status and Parental Awareness in Children with X-Linked Hypophosphatemic Rickets: A Case-Control Study.X连锁低磷性佝偻病患儿的口腔健康状况及家长认知:一项病例对照研究
Reports (MDPI). 2025 Aug 20;8(3):151. doi: 10.3390/reports8030151.
3
Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan.

本文引用的文献

1
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.随机试验抗 FGF23 抗体 KRN23 在 X 连锁低磷血症。
J Clin Invest. 2014 Apr;124(4):1587-97. doi: 10.1172/JCI72829. Epub 2014 Feb 24.
2
Hearing loss is part of the clinical picture of ENPP1 loss of function mutation.听力损失是ENPP1功能丧失性突变临床症状的一部分。
Horm Res Paediatr. 2014;81(1):63-6. doi: 10.1159/000354661. Epub 2013 Nov 6.
3
Novel bone endocrine networks integrating mineral and energy metabolism.新型骨内分泌网络整合了矿物质和能量代谢。
关于X连锁低磷血症患者全生命周期管理与治疗的专家共识。
J Endocrinol Invest. 2025 Jul 1. doi: 10.1007/s40618-025-02611-7.
4
[Surgical strategies for osteotomy correction of severe lower limb deformities in hypophosphatemic rickets].[低磷性佝偻病严重下肢畸形截骨矫正的手术策略]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Jun 15;39(6):701-707. doi: 10.7507/1002-1892.202503128.
5
Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin D.接受磷酸盐补充剂和活性维生素D治疗的X连锁低磷血症患儿横向身体维度和比例的生长动态及相关临床决定因素。
Pediatr Nephrol. 2025 Jun 10. doi: 10.1007/s00467-025-06841-y.
6
Impact of burosumab on lower limb alignment in children with X-linked hypophosphatemia.布罗索尤单抗对X连锁低磷血症患儿下肢对线的影响。
J Pediatr Soc North Am. 2024 Feb 28;6:100012. doi: 10.1016/j.jposna.2024.100012. eCollection 2024 Feb.
7
Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults With X-Linked Hypophosphatemia.布罗索尤单抗与口服磷酸盐和活性维生素D治疗成人X连锁低磷血症的真实世界疗效比较
J Bone Miner Res. 2025 May 2. doi: 10.1093/jbmr/zjaf063.
8
The Burden of Adult X-Linked Hypophosphatemia on Carers and Family Members: A Mixed-Methods Study.成人X连锁低磷血症对护理人员和家庭成员的负担:一项混合方法研究。
J Health Econ Outcomes Res. 2025 Apr 24;12(1):162-170. doi: 10.36469/001c.133860. eCollection 2025.
9
A Comprehensive Review of Electrolyte Imbalances and Their Applied Aspects in Dermatology.电解质失衡及其在皮肤科应用方面的综合综述
Cureus. 2025 Mar 28;17(3):e81353. doi: 10.7759/cureus.81353. eCollection 2025 Mar.
10
A literature review of the healthcare resource use and productivity burden of X-linked hypophosphataemia.X连锁低磷血症的医疗资源利用和生产力负担的文献综述。
Front Health Serv. 2025 Apr 9;5:1285246. doi: 10.3389/frhs.2025.1285246. eCollection 2025.
Curr Osteoporos Rep. 2013 Dec;11(4):391-9. doi: 10.1007/s11914-013-0178-8.
4
Topical fluoride for caries prevention: executive summary of the updated clinical recommendations and supporting systematic review.用于预防龋齿的局部用氟化物:最新临床建议及相关系统评价的执行摘要
J Am Dent Assoc. 2013 Nov;144(11):1279-91. doi: 10.14219/jada.archive.2013.0057.
5
Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.HRAS 和 NRAS 中的多谱系体细胞激活突变导致镶嵌性皮肤和骨骼病变、FGF23 升高和低磷血症。
Hum Mol Genet. 2014 Jan 15;23(2):397-407. doi: 10.1093/hmg/ddt429. Epub 2013 Sep 4.
6
Deliberate total parathyroidectomy: a potentially novel therapy for tumor-induced hypophosphatemic osteomalacia.甲状旁腺全切除术:一种潜在的新型肿瘤性低磷血症性骨软化症治疗方法。
J Clin Endocrinol Metab. 2013 Nov;98(11):4273-8. doi: 10.1210/jc.2013-2705. Epub 2013 Aug 16.
7
The muscle-bone relationship in X-linked hypophosphatemic rickets.X 连锁低磷血症性佝偻病的肌肉骨骼关系。
J Clin Endocrinol Metab. 2013 May;98(5):E990-5. doi: 10.1210/jc.2012-4146. Epub 2013 Mar 22.
8
Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.透析患者的低体重指数和血脂异常与血浆成纤维细胞生长因子 23 升高有关。
Am J Nephrol. 2013;37(3):183-90. doi: 10.1159/000346941. Epub 2013 Feb 20.
9
Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.成骨细胞调节磷酸盐稳态和矿化作用是遗传性佝偻病和骨软化症病理生理学的基础。
Bone. 2013 Jun;54(2):213-21. doi: 10.1016/j.bone.2013.01.046. Epub 2013 Feb 9.
10
Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification.外显子组测序揭示 FAM20c 突变与成纤维细胞生长因子 23 相关低磷血症、牙齿异常和异位钙化有关。
J Bone Miner Res. 2013 Jun;28(6):1378-85. doi: 10.1002/jbmr.1850.